In the face of the delta variant taking hold in the U.S., pandemic-driven demand for packaged foods could be sticking around for longer than had… Read More »Continued Demand For Packaged Food Amid Delta Could Make This Stock A Sweet Deal – Literally.
The clinical-stage biopharmaceutical company discussed in today’s article, which is focused on developing innovative cancer therapies.
COVID case numbers are surging again thanks the Delta variant, and concerns that this will result in more lockdowns and travel restrictions may be part of the reason for the recent pullback in oil and gas prices.
“Wall Street analysts following these biotechs have high expectations for the drugs they’re developing and in one case already marketing.
“When it comes to investing in biotech penny stocks, there are some ways to dramatically increase your chances of success and to give yourself a good chance of becoming a millionaire or even a multimillionaire in the process.”
“New therapies derived from psychedelic compounds…are offering hope, not to mention a slew of opportunities for forward-thinking investors.”